|
|
|
| Cipla launches generic drug to treat H1N1 | 12-NOV-09 |
|
| Indian drug major Cipla has launched generic versions of anti-flu drugs oseltamivir and zanamivir in the local market to treat the H1N1 influenza, which is spreading across the globe and in India. |
|
|
|
|
|
|
| Mankind vs Goliaths | 03-NOV-09 |
|
| Little-known Mankind Pharma has earned a name for itself with cheap drugs. Can it move up the value chain?. |
|
|
|
| Cipla to launch ayurveda and homeo products in India | 30-OCT-09 |
|
| Pharmaceutical major Cipla India Ltd., under the brand name of its associate, L'amar Natural Products Pvt Ltd, will launch ayurvedic, homeopathic and cosmetic products in India in the coming months. The company, which launched its baby products recently, is in the process of research and development on its ayurvedic product, which includes diabetic capsules and the richest antioxidant, according to Ashok Naik, national sales manager — OTC division Cipla India Ltd. |
|
|
|
| Forex gains push Cipla Q2 net up 82% | 29-OCT-09 |
|
| An increase in exports — mainly of active pharmaceutical ingredients (API) — and foreign exchange gains have helped Cipla, the domestic drug major, post a jump of 82.1 per cent in its net profit for the July-September quarter. |
|
|
|
|
|
|
| 130 firms trade at all-time highs on BSE | 16-OCT-09 |
|
| The list includes 68 penny stocks on BSE which had a share price below Rs 10 trading near their lifetime highs. Another 512 stocks hit their 52-week highs on BSE, indicating a broad-based rally in the markets. Among the 'A' group stocks trading near their all-time highs are Bank of Baroda, Bajaj Auto, Cipla, Colgate, Dabur India, ITC, Jindal Steel, Punjab National Bank, Sesa Goa and GAIL. |
|
|
|
|
|
|
|
|
|
|
|
|
| Cipla to offload 4% stake for Rs 840 crore | 23-SEP-09 |
|
| Leading domestic drug maker Cipla will sell about four per cent of its equity to institutional investors to raise close to $175 million (Rs 840 crore) to fund its capital expansion plans. |
|
|
|
| Cipla denies reports of unrest at Sikkim facility | 22-SEP-09 |
|
| Pharmaceutical major Cipla has downplayed reports of employee unrest at its new drug manufacturing facility in Sikkim. Reports in some Sikkim-based newspapers said over 250 Cipla workers were protesting against the company’s failure to honour commitments made to them. |
|
|
|
|
|
|
| SC issues notices to Centre, others on Novartis petition | 11-SEP-09 |
|
| The Supreme Court today issued notices to the Centre, pharma major Cipla, Ranbaxy Lab, Hetero Drugs, Natco Pharma and others on a pettion filed by Swiss firm Novartis AG challenging the denial of patent for its blood cancer drug Glivec in beta crystal form. |
|
|
|
Content Guide
